Breaking News, Collaborations & Alliances

3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement

Looking towards completing production in 2021.

By: Contract Pharma

Contract Pharma Staff

3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement with SpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. Oxford, UK-based SpyBiotech selected 3P Biopharmaceuticals in June 2019 to manufacture a cGMP batch of their virus-like-particle carrier with the goal of completing production in 2021. This...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters